drugset / Trial / NCT00469053

Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509)

NCT00469053 ↗

Phase 1 Terminated 36 enrolled Grünenthal GmbH
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine whether two different analgesic transdermal patch formulations lead to same plasma levels of active ingredient after multiple dose application.

Timeline

Start
2007-05
Primary completion
—
Completion
2007-11

Outcome

Outcome not reported

Stopped: “The trail end was achived according to the definition in the trial protocol”

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified — Other

Indications

No indication recorded.